The Experts in Animal Health

printer friendly

Brakke Consulting’s
Animal Health News & Notes for June 26, 2015

Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
Brakke Consulting news
Industry webinar
Strategic planning
other news
Actinobac Biomed
ARK Animal Health
Henry Schein
Jorgen Kruuse
Marfrig Global Foods
Nestle Purina
SunTech Medical
Thermo Fisher Scientific
Valeant Pharmaceuticals
VetCell Therapeutics
JULY 7, 2015

Brakke Consulting, Inc. will present a two-hour webinar entitled “The U.S. Animal Health Industry” on Tuesday, July 7 from 11 am – 1 pm CDT.
Presented by senior consultants John Volk and David Goodnight, DVM, MBA, the two-hour presentation will include a review of the current issues impacting the U.S. animal health industry and veterinary profession. The webinar will also highlight results of a just-completed study on how pet owners are changing their purchasing patterns for animal health products. Participants will also have the opportunity to ask questions.

The cost of registering for the webinar is $385 per person. The deadline for registering is Wednesday, July 1.

To register, go to and scroll down to the “What’s new” area. 

> Valeant Pharmaceuticals International Inc. has reportedly made a preliminary approach to acquire Zoetis Inc.  Zoetis shares, which were already trading at all-time highs, rose 11% on the news. (Wall Street Journal)
> Actinobac Biomed, Inc., announced that it has signed an agreement with Elanco Animal Health to license Actinobac’s non-human rights for the therapeutic uses of its primary drug candidate, Leukothera, in food animal and companion animal diseases. (PRNewswire)
> Nestle Purina announced the launch of its first natural therapeutic diet: Purina Pro Plan Veterinary Diets EN Gastroenteric Naturals with Added Vitamins and Minerals Canine and Feline Formulas. The new products will debut in both canine and feline formulations and dry and canned varieties. (company press release) 
> ARK Animal Health announced the FDA granted a Minor Use/Minor Species (MUMS) Drug Designation for ARK-001. ARK-001, which contains the active ingredient resiniferatoxin (also known as RTX), is being developed for the control of pain associated with bone cancer in dogs. (PRNewswire) 
> PrimeGen Biotech, a pioneer in the research and discovery of practical therapeutic uses for stem cells, announced the opening of its VetCell Therapeutics subsidiary. The VetCell team is dedicated to the research and development of safe and affordable new therapies for pets and companion animals through the use of many types of stem cells. (company press release) 
> The World Organization for Animal Health (OIE) approved the registration of the Bovigam TB Kit from Thermo Fisher Scientific in the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2015. It is the only bovine tuberculosis (bTB), Interferon-gamma in vitro assay that is OIE-registered. The kit is validated for use in cattle, goat, buffalo and sheep. (PRNewswire) 
> SunTech Medical announced the launch of the SunTech Vet20, an automated blood pressure monitor that allows veterinarians to take fast, simple and accurate blood pressure measurements on awake or sedated companion animals. (DVM360)
> Esaote announced the launch of the MyLabGamma and MyLabSix ultrasound platforms for general practice veterinarians, along with the MyLabAlpha and MyLabSeven platforms for specialists. In addition, Esaote introduces OPUS, its One Probe Ultrasound Solution. (DVM360) 
> Electronic Billing & Customer Support (EBCS), a payment processing company that has provided payment management solutions for a variety of businesses since 1986, announced the launch of, an easy-to-use platform for offering installment payment plans to their clients. (company press release)
> EUROPE  Henry Schein announced that it will acquire a majority (85%) stake in Jorgen Kruuse A/S, a distributor of veterinary products in Scandinavia. The Kruuse family will retain the remaining 15%. The deal will extend the reach of Schein’s animal health business into Denmark, Norway and Sweden. Financial terms of the deal were not disclosed, but Kruuse had 2014 sales of about $90 million. ( 
> EUROPE  Marfrig Global Foods announced the sale of its entire Moy Park business unit to JBS S.A., for $1.5 billion. Moy Park is one of the largest producers of organic, free range and corn fed poultry in Europe. The deal will include a payment of $1.19 billion in cash to Marfrig at the time of closing the deal, as well as the assumption of Moy Park’s net debt of GBP 200 million. (Feedstuffs) 
> US – CATTLE HERD  The USDA reported that cattle and calves on feed for slaughter market in the US for feedlots with capacity of 1,000 or more head totaled 10.6 million head on June 1, 2015. The inventory was 1% above June 1, 2014. Placements in feedlots during May totaled 1.71 million, 10% below 2014. Net placements were 1.63 million head. (Vet Advantage)

Brakke Consulting is an excellent resource for your company’s strategic planning. Some of the services we offer include:
– Reviewing revenue estimates and success probability of your product pipeline.
– Reviewing the timing of various new product introductions and estimate the impact of various scenarios.
– Benchmarking various functions against company competitors in the larger markets, which might include sales force size, technical services and/or R&D spending vs. sales.

Through strategic planning, Brakke Consulting can help improve the likelihood of success for your company’s future endeavors.

Contact us for professional assistance in any of these areas. 
The news this week is covers a number of international licensings, product launches and acquisitions. Several of these announcements relate to new technology improvements for various diagnostic products. We continue to believe that new diagnostics will be the one of the leading growth areas in animal health in the next few years. Diagnostics improve veterinary care for both food and companion animals.

Our feedback from the field this week is that most companies are expecting reasonably strong financial results for the first half of 2015. With just a few days left in June, it will not belong until we’ll start seeing the actual reports.

For those of you interesting in learning more about the trends in the US Animal Health Industry in 2015 and forward, we would encourage you to register for our 2-hour webinar that is advertised earlier in this newsletter. This is an update of our earlier NAVC and WVC presentations. There have been a number of changes during the past few months that will have an impact on year-end results for some product categories and programs. We look forward to having you join us for this informative webinar. 

Have a great weekend!
Ron Brakke
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services nd syndicated studies, visit our website at
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA


en_USEnglish (United States)